IgA nephropathy associated with axial spondyloarthritis responding to treatment by etanercept: A case report
ConclusionEtanercept may be a potentially effective option for treating IgA nephropathy associated with axial SpA.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research
More News: Ankylosing Spondylitis | Congo Health | Egypt Health | Enbrel | Laboratory Medicine | Proteinuria | Remicade | Rheumatology